Therapeutic Indications

Cefepime is indicated for:

Intra-abdominal infections, peritonitis, biliary tract infections

Irrespective of gender only Infants (40 days - 1 year old) , Children (1 year - 12 years old)

Cefepime is indicated in the treatment of infections caused by bacteria that are cefepime-sensitive: intra-abdominal infections, including peritonitis and biliary tract infections.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 100-150 mg/kg in 2-3 divided doses daily

Lower respiratory tract infections

Irrespective of gender only Infants (40 days - 1 year old) , Children (1 year - 12 years old)

Cefepime is indicated in the treatment of infections caused by bacteria that are cefepime-sensitive: lower respiratory tract infections, including nosocomial pneumonia and community acquired pneumonia, acute bacterial exacerbation of chronic bronchitis and secondary bacterial infection of acute bronchitis.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 100-150 mg/kg in 2-3 divided doses daily

Infection of skin and/or subcutaneous tissue

Irrespective of gender only Infants (40 days - 1 year old) , Children (1 year - 12 years old)

Cefepime is indicated in the treatment of infections caused by bacteria that are cefepime-sensitive: skin and subcutaneous infections.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 100-150 mg/kg in 2-3 divided doses daily

Uncomplicated and complicated urinary tract infections

Irrespective of gender only Infants (40 days - 1 year old) , Children (1 year - 12 years old)

Cefepime is indicated in the treatment of infections caused by bacteria that are cefepime-sensitive: uncomplicated and complicated urinary tract infections, including pyelonephritis.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 100-150 mg/kg in 2-3 divided doses daily

Bacterial infection with neutropenic fever

Irrespective of gender only Infants (40 days - 1 year old) , Children (1 year - 12 years old)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 150 mg/kg in 3 divided doses daily

Bacterial meningitis

Irrespective of gender only Infants (40 days - 1 year old) , Children (1 year - 12 years old)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 150 mg/kg in 3 divided doses daily

Intra-abdominal infections, peritonitis, biliary tract infections

Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)

Cefepime is indicated in the treatment of infections caused by bacteria that are cefepime-sensitive: intra-abdominal infections, including peritonitis and biliary tract infections.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 4-6 g in 2-3 divided doses daily

Lower respiratory tract infections

Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)

Cefepime is indicated in the treatment of infections caused by bacteria that are cefepime-sensitive: lower respiratory tract infections, including nosocomial pneumonia and community acquired pneumonia, acute bacterial exacerbation of chronic bronchitis and secondary bacterial infection of acute bronchitis.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 4-6 g in 2-3 divided doses daily

Infection of skin and/or subcutaneous tissue

Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)

Cefepime is indicated in the treatment of infections caused by bacteria that are cefepime-sensitive: skin and subcutaneous infections.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 4-6 g in 2-3 divided doses daily

Gynaecological infections

Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 4-6 g in 2-3 divided doses daily

Uncomplicated and complicated urinary tract infections

Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)

Cefepime is indicated in the treatment of infections caused by bacteria that are cefepime-sensitive: uncomplicated and complicated urinary tract infections, including pyelonephritis.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 1-6 g in 2-3 divided doses daily

Bacterial infection with neutropenic fever

Irrespective of gender only Adolescents (12 years - 18 years old) Adults (18 years old or older)

In combination with other antibacterial agents in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection.

For this indication, the medical literature mentions below treatments (click for details):

Treatment 1: Intravenous - 4-6 g in 2-3 divided doses daily

Contraindications

Active ingredient Cefepime is contraindicated in the following cases:

Hypersensitivity to cephalosporins

No gender/age discrimination

Hypersensitivity to cefepime, to any other cephalosporin.